Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 18;31(4):658-668.e14.
doi: 10.1016/j.chembiol.2024.02.004. Epub 2024 Mar 19.

PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication

Affiliations

PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication

Lori A Emert-Sedlak et al. Cell Chem Biol. .

Abstract

The HIV-1 Nef accessory factor enhances the viral life cycle in vivo, promotes immune escape of HIV-infected cells, and represents an attractive antiretroviral drug target. However, Nef lacks enzymatic activity and an active site, complicating traditional occupancy-based drug development. Here we describe the development of proteolysis targeting chimeras (PROTACs) for the targeted degradation of Nef. Nef-binding compounds, based on an existing hydroxypyrazole core, were coupled to ligands for ubiquitin E3 ligases via flexible linkers. The resulting bivalent PROTACs induced formation of a ternary complex between Nef and the cereblon E3 ubiquitin ligase thalidomide-binding domain in vitro and triggered Nef degradation in a T cell expression system. Nef-directed PROTACs efficiently rescued Nef-mediated MHC-I and CD4 downregulation in T cells and suppressed HIV-1 replication in donor PBMCs. Targeted degradation is anticipated to reverse all HIV-1 Nef functions and may help restore adaptive immune responses against HIV-1 reservoir cells in vivo.

Keywords: CD4; HIV Nef; HIV-1; MHC-I; PROTACs; antiretroviral drugs; targeted degradation.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Update of

Comment in

  • PROTAC induces HIV-1 Nef degradation.
    Crunkhorn S. Crunkhorn S. Nat Rev Drug Discov. 2024 May;23(5):340. doi: 10.1038/d41573-024-00060-0. Nat Rev Drug Discov. 2024. PMID: 38575781 No abstract available.

Similar articles

References

    1. Pawlak EN, and Dikeakos JD (2015). HIV-1 Nef: a master manipulator of the membrane trafficking machinery mediating immune evasion. Biochim. Biophys. Acta 1850, 733–741. S0304-4165(15)00022-7 [pii];10.1016/j.bbagen.2015.01.003 [doi]. - DOI - PubMed
    1. Buffalo CZ, Iwamoto Y, Hurley JH, and Ren X (2019). How HIV Nef Proteins Hijack Membrane Traffic To Promote Infection. J Virol 93, e01322. 10.1128/JVI.01322-19. - DOI - PMC - PubMed
    1. Rosa A, Chande A, Ziglio S, De, S. V, Bertorelli R, Goh SL, McCauley SM, Nowosielska A, Antonarakis SE, Luban J, et al. (2015). HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature 526, 212–217. nature15399 [pii];10.1038/nature15399 [doi]. - DOI - PMC - PubMed
    1. Usami Y, Wu Y, and Gottlinger HG (2015). SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature 526, 218–223. nature15400 [pii];10.1038/nature15400 [doi]. - DOI - PMC - PubMed
    1. Bregnard C, Zamborlini A, Leduc M, Chafey P, Camoin L, Saib A, Benichou S, Danos O, and Basmaciogullari S (2013). Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity. J. Virol 87, 3729–3740. JVI.02477-12 [pii]; 10.1128/JVI.02477-12 [doi]. - DOI - PMC - PubMed

Substances

LinkOut - more resources